Charles Schwab’s PHARMACYCLICS INC PCYC Stock Holding History

Charles Schwab’s Portfolio PCYC Stock Details PCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-110,575	Closed	-$28.3M	–	3202
2015 Q1	$28.3M	Buy	110,575 +11,500	+12%	+$2.22M	0.04%	444
2014 Q4	$12.1M	Buy	99,075 +5,110	+5%	+$653K	0.02%	763
2014 Q3	$11M	Sell	93,965 -1,624	-2%	-$185K	0.02%	744
2014 Q2	$8.58M	Buy	95,589 +4,064	+4%	+$381K	0.01%	958
2014 Q1	$9.17M	Buy	91,525 +8,099	+10%	+$1.05M	0.02%	874
2013 Q4	$8.82M	Buy	83,426 +7,183	+9%	+$872K	0.02%	810
2013 Q3	$10.7M	Buy	76,243 +24,192	+46%	+$2.68M	0.02%	613
2013 Q2	$4.45M	Buy	+52,051	New	+$4.25M	0.01%	1158

Other funds holding PCYC

Credit Agricole Montrouge Cedex, France $38.1B AUM

Charles Schwab's PCYC Position: Q2 2015 in Review

Charles Schwab sold out of PHARMACYCLICS INC (PCYC) in Q2 2015, closing a stake of 110,575 shares — an estimated $28.3M sold.

Charles Schwab first reported a position in PCYC in Q2 2013 and held it in 8 quarters. The position peaked at $28.3M in Q1 2015. 1 fund tracked by Wall St. Rank holds PCYC as of Q2 2015.

Charles Schwab reported no remaining PHARMACYCLICS INC position as of Q2 2015 after selling out during the quarter.
Charles Schwab sold 110,575 PHARMACYCLICS INC shares in Q2 2015, an estimated $28.3M.
Charles Schwab first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 8 quarters.
Charles Schwab's PHARMACYCLICS INC position peaked at $28.3M in Q1 2015.
1 fund tracked by Wall St. Rank held PHARMACYCLICS INC as of Q2 2015.

Based on Charles Schwab's 13F filing for Q2 2015, filed 14 Aug 2015.